Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models

Biotechnology and Bioengineering

Volumn 111, Issue 8, 2014, Pages 1672-1685

  Costa, Elisabete C ^a   Gaspar, Vítor M ^a   Coutinho, Paula ^a,b   Correia, Ilídio J ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b POLYTECHNIC INSTITUTE OF GUARDA   (Portugal)

Author keywords

3D MCTS; Cancer; In vitro models; LOT; Tumor microenvironment

Indexed keywords

CELL CULTURE; LIQUIDS; TUMORS;

3D MCTS; CANCER; IN-VITRO MODELS; LOT; TUMOR MICROENVIRONMENT;

DIAGNOSIS;

AGAROSE;

ARTICLE; CANCER CELL; CELL AGGREGATION; COCULTURE; CONTROLLED STUDY; CULTURE OPTIMIZATION; CYTOARCHITECTURE; HUMAN; HUMAN CELL; LIQUID OVERLAY TECHNIQUE; PHASE CONTRAST MICROSCOPY; SCREENING; STROMA CELL; TUMOR SPHEROID; CYTOLOGY; DEVICES; DRUG SCREENING; EQUIPMENT DESIGN; MULTICELLULAR SPHEROID; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE; TUMOR CELL LINE;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; DRUG SCREENING ASSAYS, ANTITUMOR; EQUIPMENT DESIGN; HUMANS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84903276548     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25210     Document Type: Article

References (57)

1. Aboussekhra A. 2011. Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol 55(7-9):841-849.
2. Akgül B, Lin K-W, Yang H-MO, Chen Y-H, Lu T-H, Chen C-H, Kikuchi T, Chen Y-T, Tu C-PD. 2010. Garlic accelerates red blood cell turnover and splenic erythropoietic gene expression in mice: Evidence for erythropoietin-independent erythropoiesis. PLoS ONE 5(12):e15358.
3. Almendro V, Marusyk A, Polyak K. 2013. Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol 8:277-302.
4. Box C, Rogers SJ, Mendiola M, Eccles SA. 2010. Tumour-microenvironmental interactions: Paths to progression and targets for treatment. Semin Cancer Biol 20(3):128-138.
5. Burdett E, Kasper FK, Mikos AG, Ludwig JA. 2010. Engineering tumors: A tissue engineering perspective in cancer biology. Tissue Eng Part B Rev 16(3):351-359.
6. Corti A, Pastorino F, Curnis F, Arap W, Ponzoni M, Pasqualini R. 2012. Targeted drug delivery and penetration into solid tumors. Med Res Rev 32(5):1078-1091.
7. Costa EC, Gaspar VM, Marques JG, Coutinho P, Correia IJ. 2013. Evaluation of nanoparticle uptake in co-culture cancer models. PLoS ONE 8(7):e70072.
8. Delinassios J, Kottaridis S. 1984. Interactions between human fibroblasts and HeLa cells in vitro. Biol Cell 50(1):9-16.
9. Delinassios J. 1987. Cytocidal effects of human fibroblasts on HeLa cells in vitro. Biol Cell 59(1):69-77.
10. do Amaral JB, Rezende-Teixeira P, Freitas VM, Machado-Santelli GM. 2011. MCF-7 cells as a three-dimensional model for the study of human breast cancer. Tissue Eng Part C Methods 17(11):1097-1107.
11. Durek C, Brandau S, Ulmer AJ, Flad H, Jocham D, Bohle A. 1999. Bacillus-Calmette-Guerin (BCG) and 3D tumors: An in vitro model for the study of adhesion and invasion. J Urol 162(2):600-605.
12. Fennema E, Rivron N, Rouwkema J, van Blitterswijk C, de Boer J. 2013. Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol 31(2):108-115.
13. Ferdowsian HR, Beck N. 2011. Ethical and scientific considerations regarding animal testing and research. PLoS ONE 6(9):e24059.
14. Fletcher DA, Mullins RD. 2010. Cell mechanics and the cytoskeleton. Nature 463(7280):485-492.
15. Friedrich J, Ebner R, Kunz-Schughart LA. 2007. Experimental anti-tumor therapy in 3-D: Spheroids-old hat or new challenge? Int J Radiat Biol 83(11-12):849-871.
16. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. 2009. Spheroid-based drug screen: Considerations and practical approach. Nat Protoc 4(3):309-324.
17. Gaspar VM, Correia IJ Sousa Â, Silva F, Paquete CM, Queiroz JA, Sousa F. 2011. Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy. J Control Release 156(2):212-222.
18. Goodman TT, Olive PL, Pun SH. 2007. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomed 2(2):265-274.
19. Hanahan D, Coussens LM. 2012. Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3):309-322.
20. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144(5):646-674.
21. Heneweer M, Muusse M, Dingemans M, De Jong PC, Van Den Berg M, Sanderson JT. 2005. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model. Toxicol Sci 83(2):257-263.
22. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. 2010. Multicellular tumor spheroids: An underestimated tool is catching up again. J Biotechnol 148(1):3-15.
23. Jiang X, Sha X, Xin H, Xu X, Gu J, Xia W, Chen S, Xie Y, Chen L, Chen Y. 2013. Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly (trimethylene carbonate)-based nanoparticles encapsulating paclitaxel. Biomaterials 34(12):2969-2979.
24. Jou C-H, Chen W-C, Yang M-C, Hwang M-C, Chou W-L, Lin S-M, Hsu CY. 2008. In vitro biocompatibility of three-dimensional chitosan scaffolds immobilized with chondroitin-6-sulfate. Polym Adv Technol 19(5):377-384.
25. Justice BA, Badr NA, Felder RA. 2009. 3D cell culture opens new dimensions in cell-based assays. Drug Discov Today 14(1):102-107.
26. Kalluri R, Zeisberg M. 2006. Fibroblasts in cancer. Nat Rev Cancer 6(5):392-401.
27. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW. 2007. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 1(1):84-96.
28. Kim JB, Stein R, O'Hare MJ. 2004. Three-dimensional in vitro tissue culture models of breast cancer-a review. Breast Cancer Res Treat 85(3):281-291.
29. Ko YH, Lin Z, Flomenberg N, Pestell RG, Howell A, Sotgia F, Lisanti MP, Martinez-Outschoorn UE. 2012. Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells. Cancer Biol Ther 12(12):1085-1097.
30. Koontongkaew S. 2013. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer 4(1):66-83.
31. LaBarbera DV, Reid BG, Yoo BH. 2012. The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin Drug Discov 7(9):819-830.
32. Lin R-Z, Chang H-Y. 2008. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 3(9-10):1172-1184.
33. Lu P, Weaver VM, Werb Z. 2012. The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol 196(4):395-406.
34. Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, Migneco G, Witkiewicz AK, Martinez-Cantarin MP, Flomenberg N. 2010. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 9(12):2423-2433.
35. Marx V. 2013. Cell culture: A better brew. Nature 496(7444):253-258.
36. Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S. 2012. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release 164(2):192-204.
37. Metzger W, Sossong D, Bächle A, Pütz N, Wennemuth G, Pohlemann T, Oberringer M. 2011. The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells. Cytotherapy 13(8):1000-1012.
38. Mikhail AS, Eetezadi S, Allen C. 2013. Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: A comparison of docetaxel-loaded block copolymer micelles and Taxotere®. PLoS ONE 8(4):e62630.
39. Miki Y, Ono K, Hata S, Suzuki T, Kumamoto H, Sasano H. 2012. The advantages of co-culture over mono cell culture in simulating in vivo environment. J Steroid Biochem Mol Biol 131(3-5):68-75.
40. Nagelkerke A, Bussink J, Sweep FC, Span PN. 2013. Generation of multicellular tumor spheroids of breast cancer cells: How to go three-dimensional. Anal Biochem 437(1):17-19.
41. Page H, Flood P, Reynaud EG. 2013. Three-dimensional tissue cultures: Current trends and beyond. Cell Tissue Res 352(1):123-131.
42. Pietras K, Östman A. 2010. Hallmarks of cancer: Interactions with the tumor stroma. Exp Cell Res 316(8):1324-1331.
43. Prados J, Melguizo C, Rama A, Ortiz R, Boulaiz H, Rodriguez-Serrano F, Caba O, Rodriguez-Herva JJ, Ramos JL, Aranega A. 2008. Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells. Int J Oncol 33(1):121-127.
44. Rasband WS. 1997. ImageJ. US National Institutes of Health Bethesda, MD.
45. Ribeiro M, Morgado P, Miguel S, Coutinho P, Correia I. 2013. Dextran based-hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing. Mater Sci Eng C Mater Biol Appl 33(5):2958-2966.
46. Rimann M, Graf-Hausner U. 2012. Synthetic 3D multicellular systems for drug development. Curr Opin Biotechnol 23(5):803-809.
47. Schönberger J, Bauer J, Spruß T, Weber G, Chahoud I, Eilles C, Grimm D. 2000. Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med 78(2):102-110.
48. Shojaei F. 2012. Anti-angiogenesis therapy in cancer: Current challenges and future perspectives. Cancer lett 320(2):130-137.
49. Singh S, Kaur H. 2013. Tumor microenvironment: A review. J Oral Maxillofac Surg Med Pathol.
50. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT. 2012. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487(7408):500-504.
51. Trédan O, Galmarini CM, Patel K, Tannock IF. 2007. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99(19):1441-1454.
52. Wang J, Levenson AS, Satcher RL, Jr. 2006. Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis. Int J Mol Med 17(5):849-856.
53. Weigelt B, Geyer FC, Reis-Filho JS. 2010. Histological types of breast cancer: How special are they? Mol Oncol 4(3):192-208.
54. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, Birbe RC, Howell A, Pavlides S, Gandara R. 2011. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 10(11):1772-1783.
55. Wong C, Vosburgh E, Levine AJ, Cong L, Xu EY. 2012. Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy. J Vis Exp (66): e4218.
56. Yeom CJ, Goto Y, Zhu Y, Hiraoka M, Harada H. 2012. Microenvironments and cellular characteristics in the micro tumor cords of malignant solid tumors. Int J Mol Sci 13(11):13949-13965.
57. Yeon S-E, Lee S-H, Nam SW, Oh I-H, Lee J, Kuh H-J. 2013. Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model. PLoS ONE 8(9):e73345.